Meeting Overview - The fifth extraordinary general meeting of shareholders was held on October 10, 2025, at the company's conference room [2] - The meeting was conducted in accordance with the Company Law and the company's articles of association, combining on-site and online voting [2][3] Attendance and Voting - All 15 current directors and 5 supervisors attended the meeting, along with the board secretary [3] - The meeting's agenda included a non-cumulative voting proposal regarding the use of idle funds to purchase bank wealth management products, which was approved [3][4] Legal Verification - The meeting was witnessed by lawyers from Inner Mongolia Jianzhong Law Firm, who confirmed that the meeting's procedures complied with relevant laws and regulations [4] - The legal opinion stated that the qualifications of attendees were valid and the voting procedures and results were legitimate [4]
天士力医药集团股份有限公司2025年第五次临时股东大会决议公告